Key features :

• Reduced Metal Content: Enhances the device’s flexibility.
• Titanium Oxide Surface: Provides a “golden” appearance to the nitinol wires, ensuring resistance to oxidation and corrosion within the bloodstream.
• Nitinol Wires: Range from 40 to 200 microns in diameter, balancing stability and flexibility.
• Polyethylene Terephthalate (PET) Patch: Biologically inert, promoting rapid tissue growth.

Advanced Delivery System

The Occlutech ASD Occluder features an advanced delivery system designed to ensure precise placement with minimal drag or undesirable traction. This system includes:

• Left Atrial Disk: Reduced material for quicker endothelial coverage and lower thrombus formation risk.
• Flexible Delivery System: Allows accurate positioning, reducing the risk of vein perforation.

Clinical Studies

The Occlutech ASD Occluder has been part of the largest ASD trial ever published, demonstrating:

• High Implantation Success Rate
• High Closure Rates
• Short Fluoroscopy Time
• Handling of Complex ASD Anatomies

The IRFACODE trial highlighted that our occluder should be the first choice for ASD closure due to extremely low rates of embolization, AV blocks, erosion, and zero reported deaths.

Atrial Septal Defect (ASD) is a common congenital heart defect characterized by a hole in the septum between the heart’s two upper chambers (atria). This condition allows blood to flow from the left atrium to the right atrium, which can lead to complications if left untreated. ASD is detected in approximately 1 in 1500 births and accounts for 30% to 40% of congenital heart diseases observed in adults. Often, it remains undiagnosed until adulthood.

Types of ASD

• Ostium Secundum (77%): The most common type suitable for closure with devices.
• Ostium Primum (20%)
• Sinus Venosus (2%)
• Coronary Sinus (rare)